Risk for kidney failure with replacement therapy lower with ACEi, ARB treatment among individuals with advanced CKD
Significantly More Weight Loss Seen With Tirzepatide Versus Semaglutide
Patients with overweight, obesity receiving tirzepatide significantly more likely to achieve ≥5, ≥10, and ≥15 percent weight loss
Study Compares Rivaroxaban, Warfarin With Apixaban for Cirrhosis, A-Fib
Initiators of rivaroxaban or warfarin versus apixaban have significantly higher rates of major hemorrhage
Almost Half of U.S. Counties Do Not Have Practicing Cardiologist
Counties without a cardiologist have higher cardiovascular risk index, higher cardiovascular mortality rates, and shorter life expectancy